William G. Humphreys

Bristol-Myers Squibb (United States)

Papers

1

Total Citations

8

H-Index

1

About

William G. Humphreys is a distinguished pharmaceutical scientist whose work centers on drug metabolism and pharmacokinetics, with a particular focus on developing innovative methods to evaluate the metabolic stability and disposition of discovery compounds. His major contributions include pioneering a semi-automated, integrated approach that simultaneously assesses both the half-life and metabolic soft spots of drug candidates—a technique that streamlines early-stage drug development by providing critical data on parent compound disappearance and metabolite formation. This work, published in 2012 and cited 8 times, demonstrates his commitment to advancing preclinical screening methodologies. Humphreys’ research has practical implications for optimizing drug design, as evidenced by his use of model compounds like buspirone, mirtazapine, and verapamil to validate his methods. His achievements reflect a career dedicated to bridging the gap between laboratory innovation and real-world pharmaceutical applications, making him a valuable contributor to the field of drug metabolism and a resource for researchers seeking efficient, high-throughput solutions for evaluating drug candidates.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
A Semi-Automated Method For The Integrated Evaluation of Half-Life And Metabolic Soft Spots of Discovery Compounds
8 citations · 2012
📈 Most Prolific Year: 2012 (1 Papers)
🤝 Key Collaborators: 2
🏛 Institutions: Bristol-Myers Squibb (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago